Molinar-Inglis Olivia, Birch Cierra A, Nicholas Dequina, Orduña-Castillo Lennis, Cisneros-Aguirre Metztli, Patwardhan Anand, Chen Buxin, Grimsey Neil J, Coronel Luisa J, Lin Huilan, Gomez Menzies Patrick K, Lawson Mark A, Patel Hemal H, Trejo JoAnn
Department of Pharmacology, School of Medicine, University of California San Diego, La Jolla, CA 92093.
Department of Molecular Biology and Biochemistry, School of Biological Sciences, University of California, Irvine, CA 92697.
Proc Natl Acad Sci U S A. 2021 Dec 7;118(49). doi: 10.1073/pnas.2106623118.
Endothelial dysfunction is associated with vascular disease and results in disruption of endothelial barrier function and increased sensitivity to apoptosis. Currently, there are limited treatments for improving endothelial dysfunction. Activated protein C (aPC), a promising therapeutic, signals via protease-activated receptor-1 (PAR1) and mediates several cytoprotective responses, including endothelial barrier stabilization and anti-apoptotic responses. We showed that aPC-activated PAR1 signals preferentially via β-arrestin-2 (β-arr2) and dishevelled-2 (Dvl2) scaffolds rather than G proteins to promote Rac1 activation and barrier protection. However, the signaling pathways utilized by aPC/PAR1 to mediate anti-apoptotic activities are not known. aPC/PAR1 cytoprotective responses also require coreceptors; however, it is not clear how coreceptors impact different aPC/PAR1 signaling pathways to drive distinct cytoprotective responses. Here, we define a β-arr2-mediated sphingosine kinase-1 (SphK1)-sphingosine-1-phosphate receptor-1 (S1PR1)-Akt signaling axis that confers aPC/PAR1-mediated protection against cell death. Using human cultured endothelial cells, we found that endogenous PAR1 and S1PR1 coexist in caveolin-1 (Cav1)-rich microdomains and that S1PR1 coassociation with Cav1 is increased by aPC activation of PAR1. Our study further shows that aPC stimulates β-arr2-dependent SphK1 activation independent of Dvl2 and is required for transactivation of S1PR1-Akt signaling and protection against cell death. While aPC/PAR1-induced, extracellular signal-regulated kinase 1/2 (ERK1/2) activation is also dependent on β-arr2, neither SphK1 nor S1PR1 are integrated into the ERK1/2 pathway. Finally, aPC activation of PAR1-β-arr2-mediated protection against apoptosis is dependent on Cav1, the principal structural protein of endothelial caveolae. These studies reveal that different aPC/PAR1 cytoprotective responses are mediated by discrete, β-arr2-driven signaling pathways in caveolae.
内皮功能障碍与血管疾病相关,会导致内皮屏障功能破坏以及对细胞凋亡的敏感性增加。目前,改善内皮功能障碍的治疗方法有限。活化蛋白C(aPC)是一种有前景的治疗药物,它通过蛋白酶激活受体-1(PAR1)发出信号,并介导多种细胞保护反应,包括内皮屏障稳定和抗凋亡反应。我们发现,aPC激活的PAR1优先通过β-抑制蛋白-2(β-arr2)和散乱蛋白-2(Dvl2)支架而非G蛋白发出信号,以促进Rac1激活和屏障保护。然而,aPC/PAR1介导抗凋亡活性所利用的信号通路尚不清楚。aPC/PAR1的细胞保护反应也需要共受体;然而,尚不清楚共受体如何影响不同的aPC/PAR1信号通路以驱动不同的细胞保护反应。在此,我们定义了一条β-arr2介导的鞘氨醇激酶-1(SphK1)-1-磷酸鞘氨醇受体-1(S1PR1)-Akt信号轴,该信号轴赋予aPC/PAR1介导的细胞死亡保护作用。利用人培养的内皮细胞,我们发现内源性PAR1和S1PR1共存于富含小窝蛋白-1(Cav1)的微结构域中,并且PAR1的aPC激活会增加S1PR1与Cav1的共结合。我们的研究进一步表明,aPC刺激β-arr-2依赖性SphK1激活,不依赖于Dvl2,并且是S1PR1-Akt信号转激活和细胞死亡保护所必需的。虽然aPC/PAR1诱导的细胞外信号调节激酶1/2(ERK1/2)激活也依赖于β-arr2,但SphK1和S1PR1均未整合到ERK1/2通路中。最后,PAR1-β-arr2介导的aPC激活对细胞凋亡的保护作用依赖于Cav1,Cav1是内皮小窝的主要结构蛋白。这些研究表明,不同的aPC/PAR1细胞保护反应由小窝中离散的、β-arr2驱动的信号通路介导。